Literature DB >> 24325960

Use of three-dimensional speckle-tracking echocardiography for quantitative assessment of global left ventricular function: a comparative study to three-dimensional echocardiography.

Sushil A Luis1, Akira Yamada2, Bijoy K Khandheria3, Vicki Speranza1, Anthony Benjamin1, Matthew Ischenko1, David G Platts1, Christian R Hamilton-Craig1, Luke Haseler2, Darryl Burstow1, Jonathan Chan4.   

Abstract

BACKGROUND: The aim of this study was to determine whether global strains derived from three-dimensional (3D) speckle-tracking echocardiography (STE) are as accurate as left ventricular (LV) ejection fraction (LVEF) obtained by two-dimensional (2D) and 3D echocardiography in the quantification of LV function.
METHODS: Two-dimensional and 3D echocardiography and 2D and 3D STE were performed in 88 patients (LVEF range, 17%-79%). Two-dimensional and 3D global longitudinal strain (GLS), global circumferential strain (GCS), global radial strain, and global area strain were quantified and correlated with LV function determined by 2D and 3D echocardiographic LVEF. Reproducibility, feasibility, and duration of study to perform 3D STE were assessed by independent, blinded observers.
RESULTS: A total of 78 patients (89%) underwent 3D STE. All 3D speckle-tracking echocardiographic parameters had strong correlations with assessment of LV function determined by 2D and 3D echocardiographic LVEF. Three-dimensional GCS was the best marker of LV function (r = -0.89, P < .0001). Subgroup analysis demonstrated that 3D speckle-tracking echocardiographic parameters were particularly useful in identifying LV dysfunction (LVEF < 50%). Receiver operating characteristic curve analysis demonstrated areas under the curve of 0.97 for 3D GCS, 0.96 for 3D global radial strain, 0.95 for 3D global area strain, and 0.87 for 3D GLS. An optimal 3D GCS cutoff value of magnitude < -12% predicted LV dysfunction (LVEF obtained by 2D echocardiography < 50%) with 92% sensitivity and 90% specificity. There was good correlation between 2D GLS and 3D GLS (r = 0.85, P < .001; mean difference, -1.7 ± 6.5%). Good intraobserver, interobserver, and test-retest agreements were seen with 3D STE. Time for image acquisition to postprocessing analysis was significantly reduced with 3D STE (3.7 ± 1.0 minutes) compared with 2D STE (4.6 ± 1.5 min) (P < .05).
CONCLUSIONS: Global strain by 3D STE is a promising novel alternative to quantitatively assess LV function. Three-dimensional STE is reproducible, feasible, and time efficient.
Copyright © 2014 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Left ventricular function; Speckle-tracking echocardiography; Strain; Three-dimensional echocardiography

Mesh:

Year:  2013        PMID: 24325960     DOI: 10.1016/j.echo.2013.11.002

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  26 in total

1.  Incremental value of resting three-dimensional speckle-tracking echocardiography in detecting coronary artery disease.

Authors:  You-Jing Sun; Fang Wang; Rui-Sheng Zhang; Hai-Yan Wang; Chen-Guang Yang; Jie Cai; Wei-Er Zang; Ming-Zhou Li; Xin Qi; Jing Li
Journal:  Exp Ther Med       Date:  2015-04-20       Impact factor: 2.447

2.  [Echocardiographic evaluation of systolic left ventricular function in heart failure: value of alternative parameters for determination of ejection fraction].

Authors:  V Dornberger; H D Dittrich; R Busch
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

3.  Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy.

Authors:  Fei-Yan Song; Jing Shi; Ye Guo; Chu-Jie Zhang; Yu-Chen Xu; Qun-Ling Zhang; Xian-Hong Shu; Lei-Lei Cheng
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-02       Impact factor: 2.357

4.  Value of three-dimensional strain parameters for predicting left ventricular remodeling after ST-elevation myocardial infarction.

Authors:  Lin Xu; Xiaomin Huang; Jun Ma; Jiangming Huang; Yongwang Fan; Huidi Li; Jian Qiu; Heye Zhang; Wenhua Huang
Journal:  Int J Cardiovasc Imaging       Date:  2017-02-01       Impact factor: 2.357

Review 5.  Comparison of Echocardiography, Cardiac Magnetic Resonance, and Computed Tomographic Imaging for the Evaluation of Left Ventricular Myocardial Function: Part 1 (Global Assessment).

Authors:  Menhel Kinno; Prashant Nagpal; Stephen Horgan; Alfonso H Waller
Journal:  Curr Cardiol Rep       Date:  2017-01       Impact factor: 2.931

6.  Are biventricular systolic functions impaired in patient with coronoray slow flow? A prospective study with three dimensional speckle tracking.

Authors:  Tuğba Kemaloğlu Öz; Mehmet Eren; Işıl Atasoy; Tayfun Gürol; Özer Soylu; Bahadır Dağdeviren
Journal:  Int J Cardiovasc Imaging       Date:  2017-01-06       Impact factor: 2.357

7.  In-vivo validation of a new clinical tool to quantify three-dimensional myocardial strain using ultrasound.

Authors:  S Bouchez; B Heyde; D Barbosa; M Vandenheuvel; H Houle; Y Wang; J D'hooge; P F Wouters
Journal:  Int J Cardiovasc Imaging       Date:  2016-08-17       Impact factor: 2.357

8.  Two- and three-dimensional myocardial strain imaging in the interrogation of sex differences in cardiac mechanics of long-term survivors of childhood cancers.

Authors:  Vivian Wing-Yi Li; Anthony Pak-Yin Liu; Edwina Kam-Fung So; Karin Kar-Huen Ho; Jeffrey Ping-Wa Yau; Daniel Ka-Leung Cheuk; Yiu-Fai Cheung
Journal:  Int J Cardiovasc Imaging       Date:  2019-03-08       Impact factor: 2.357

9.  Assessment of subtle cardiac dysfunction in patients with frequent premature ventricular complexes by real-time three-dimensional speckle tracking echocardiography.

Authors:  Yunlong Ling; Quan Wan; Qingxing Chen; Wenqing Zhu
Journal:  Clin Cardiol       Date:  2017-05-04       Impact factor: 2.882

10.  Hcc-1 is a novel component of the nuclear matrix with growth inhibitory function.

Authors:  C L Leaw; E C Ren; M L Choong
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.